Rocket Pharmaceuticals Inc — Financial Statements (NASDAQ:RCKT) | MetaTrader

Open full chart

뉴스

RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease

Rocket Pharmaceuticals: Kresladi Validates Platform, Commercial Upside Limited (RCKT)

Rocket Pharmaceuticals, Inc. (RCKT) Discusses FDA Approval of KRESLADI Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1 Transcript

로켓 파마슈티컬, 1억 달러 규모의 시장 조성 방식 유상증자 계약 체결

Rocket Pharmaceuticals enters $100 million at-the-market offering agreement

Avago, Lumentum among market cap stock movers on Monday

Rocket Pharmaceuticals, Inc. (RCKT) Presents at TD Cowen 46th Annual Health Care Conference Transcript

RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus

Rocket Pharmaceuticals, Inc. (RCKT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Rocket Pharmaceuticals: Upside On LAD-I Approval And Amended Danon Program

Helmerich and Payne, Invivyd, Home Depot And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Alpha Technology Group (NASDAQ:ATGL), Fulcrum Therapeutics (NASDAQ:FULC)

RCKT Stock Up as FDA Accepts Resubmitted BLA for Gene Therapy